跳至主要内容
临床试验/JPRN-jRCT1070230051
JPRN-jRCT1070230051尚未招募Unknown

POSEIDON - Prevalence of systemic inflammation in patients with atherosclerotic cardiovascular disease and heart failure - POSEIDO

Tsujita Kenichi0 个研究点目标入组 1,500 人开始时间: 2023年8月23日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
>= 18age old 至 ot applicable(—)

入选标准

  • Participants are eligible to be included in the study only if all the following criteria apply:
  • 1. Informed consent obtained before any study-related activities. Study-related activities are any procedures that are carried out as part of the study.
  • 2. Age 18 years or above at the time of signing the informed consent.
  • 3. Presence of ASCVD and/or HF.
  • 4. Presence of serum creatinine in the medical chart within 24 months prior to signing of informed consent (for ASCVD patients only).

排除标准

  • Patients are excluded from the study if any of the following criteria apply:
  • 1. Previous participation in this study. Participation is defined as having given informed consent in this study.
  • 2. Current participation (i.e., signed informed consent) in any other interventional clinical study.
  • 3. Any hospitalization or unplanned visit within the last 60 days (including exacerbation of chronic disease with hospitalization).
  • 4. Clinical evidence, or suspicion of, active infection within the last 60 days.
  • 5. Mental incapacity, unwillingness, or language barriers precluding adequate understanding or cooperation.

研究者

发起方
Tsujita Kenichi

相似试验